Liechtenstein vs Netherlands: Cervical cancer screening coverage in europe
Liechtenstein
34.3
in 2022
Netherlands
45.7
in 2022
Liechtenstein rank
17th
Netherlands rank
15th
Cervical cancer screening coverage in europe over time
- Liechtenstein
- Netherlands
How they compare
Netherlands currently reports 45.7 against 34.3 in Liechtenstein, a difference of 11.4.
That makes Netherlands's figure about 1.3 times Liechtenstein's.
Across all 9 years both countries report, Netherlands has been ahead every year.
Liechtenstein ranks 17th and Netherlands ranks 15th of 23 countries.
Netherlands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Liechtenstein | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 27.8 | 59.83 | 32.03 | Netherlands |
| 2020s | 29.27 | 49.73 | 20.47 | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cervical cancer screening coverage in europe, Liechtenstein or Netherlands?
- Netherlands, at 45.7 against 34.3 in Liechtenstein as of 2022.
- What is the difference in cervical cancer screening coverage in europe between Liechtenstein and Netherlands?
- 11.4, with Netherlands ahead.
- How many years of comparable data are there for Liechtenstein and Netherlands?
- 9 years are reported by both, from 2014 to 2022.
- How do Liechtenstein and Netherlands rank globally for cervical cancer screening coverage in europe?
- Liechtenstein ranks 17th and Netherlands ranks 15th of 23 countries.
- Where does this data come from?
- Our World in Data, published as Cervical cancer screening coverage in europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.